Learn How to Start Conversations About Naloxone

The American Pharmacists Association (APhA) has just released a new resource aimed at helping pharmacists talk to their patients about naloxone use.  As APhA reports, “coprescribing naloxone to patients taking opioids has been shown to significantly reduce opioid-related harms. Greater access to naloxone has been associated with 63% fewer emergency department visits and 27%–46% fewer […]

New Idaho Bill Makes Naloxone More Available

A new bill in Idaho aims at making it easier to give out naloxone.  The current law states that a “prescriber or pharmacist” must give out naloxone, making it difficult for health systems to hold naloxone outreach programs.  The new bill, introduced this week, would replace this with “health professional.” “We want the drug in […]

Pharmacist Prescribing: Naloxone

Please see below for an updated map of naloxone access in community pharmacies across the United States, as of January 2019.   Other Naloxone Resources From Surgeon General: Advisory on Naloxone From APhA: Opioid Use, Abuse, and Misuse From CDC Opioid Prescribing: Where You Live Matters Increase in Overdose Deaths Involving Synthetic Opioids (including great fentanyl infographic) […]

Naloxone is Saving Lives in Utah

The Utah Department of Health (UDOH) has reported that 4,275 doses of naloxone were dispensed by pharmacists in 2017.  Utah is one of many states across the country with a standing order allowing pharmacists to dispense naloxone without a prescription to anyone at risk of experiencing an opioid overdose. “Every dose of naloxone we get […]

President’s Commission Releases Final Report on Opioid Crisis

The President’s Commission on Combating Drug Addiction and the Opioid Crisis released its final report this week.  The report contains 56 recommendations including an expanded drug court system, educational requirements for prescribers, and a media campaign to publicize preventative services.  The following Commission recommendations, among others, may be of particular interest to pharmacy stakeholders: “The […]